loading page

Incorporating Innovative B-Cell Targeting Therapeutics into a Combined-Modality Bridging Approach Followed by Timely Consolidative Haploidentical Transplantation to Salvage a Pediatric Patient with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
  • +6
  • Yu-Ju Chao,
  • Pei-Ing Lee,
  • Tzu-Hsien Yang,
  • Li-Hua Fang,
  • Yu-Chun Tsai,
  • Ming-Yuan Lee,
  • Yun-Hsin Wang,
  • Liuh-Yow Chen,
  • Rong-Long Chen
Yu-Ju Chao
Koo Foundation Sun Yat-Sen Cancer Center
Author Profile
Pei-Ing Lee
Koo Foundation Sun Yat-Sen Cancer Center
Author Profile
Tzu-Hsien Yang
Institute of Molecular Biology Academia Sinica
Author Profile
Li-Hua Fang
Koo Foundation Sun Yat-Sen Cancer Center
Author Profile
Yu-Chun Tsai
Koo Foundation Sun Yat-Sen Cancer Center
Author Profile
Ming-Yuan Lee
Koo Foundation Sun Yat-Sen Cancer Center
Author Profile
Yun-Hsin Wang
Koo Foundation Sun Yat-Sen Cancer Center
Author Profile
Liuh-Yow Chen
Institute of Molecular Biology Academia Sinica
Author Profile
Rong-Long Chen
Koo Foundation Sun Yat-Sen Cancer Center

Corresponding Author:[email protected]

Author Profile
09 Aug 2024Submission Checks Completed
09 Aug 2024Assigned to Editor
09 Aug 2024Submitted to Pediatric Blood & Cancer
09 Aug 2024Review(s) Completed, Editorial Evaluation Pending
12 Aug 2024Editorial Decision: Accept